NCT03068858

Brief Summary

The SYNTAX score (SS) has been recommended by clinical guideline and appropriate use criteria for coronary revascularization (CR) to provide guidance on optimal treatment strategies for patients with stable coronary artery diseases (CAD). However, discrepancy in SS between angiographic core lab (ACL) and cardiologists has been found. Whether the misestimate will lead to inappropriate CR and whether a SS intervention will improve CR appropriateness in patients with stable CAD remain unknown. Thus, our study aims at evaluating whether a real-time feedback from ACL rightafter the angiographies will improve CR appropriateness. A before-and-after controlled trial was designed. In the first period of time, stable CAD patients undergoing elective coronary angiographies with at least one coronary lesion stenosis ≥ 50% from one Chinese cardiac center will be continuously recruited as the control group. In the second period, eligible patients will be recruited continuously and a real-time SS category feedback from ACL rightafter the angiography will be given to the cardiologists. Appropriateness of treatment strategies in two groups will be analyzed to determine whether a real-time SS feedback can improve the treatment appropriateness. The appropriateness of treatment strategies will be adjudicated by Chinese version appropriate use criteria for CR.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,245

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2016

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

February 19, 2017

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 3, 2017

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2017

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2018

Completed
Last Updated

June 6, 2018

Status Verified

June 1, 2018

Enrollment Period

1 year

First QC Date

February 19, 2017

Last Update Submit

June 3, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Inappropriate rate of coronary revascularization

    Inappropriate rate will be adjudicated by Chinese appropriate use criteria for coronary revascularization.

    1 month after study completion

Secondary Outcomes (4)

  • The proportion of inappropriate PCI

    1 month after study completion

  • The proportion of inappropriate CABG

    1 month after study completion

  • The proportion of utilizing PCI procedures

    1 month after study completion

  • The proportion of utilizing CABG procedures

    1 month after study completion

Study Arms (2)

SYNTAX score category feedback group

EXPERIMENTAL

A real-time SYNTAX score category feedback from angiographic core lab will be given to the cardiologists rightafter the angiographies.

Diagnostic Test: real-time feedback of SYNTAX score category

Controlled group

NO INTERVENTION

Cardiologists' subjective SYNTAX score category judgement will be recorded during the angiography.

Interventions

SYNTAX score category feedback group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Undergo elective coronary angiography with at least one coronary lesion stenosis ≥ 50%;
  • Patients with stable coronary artery diseases (stable angina, no or non-ischemic symptom);
  • Written informed consent.

You may not qualify if:

  • Have prior CABG;
  • Have stage PCI;
  • Have no assigned scenario in Chinese appropriate use criteria.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

China National Center for Cardiovascular Diseases

Beijing, Beijing Municipality, 100037, China

Location

Related Publications (1)

  • Lin S, Zhang H, Chen SP, Rao CF, Wu F, Zhou FJ, Wang Y, Yan HB, Dou KF, Wu YJ, Tang YD, Xie LH, Guan CD, Xu B, Zheng Z. Mis-estimation of coronary lesions and rectification by SYNTAX score feedback for coronary revascularization appropriateness. Chin Med J (Engl). 2020 Jun 5;133(11):1276-1284. doi: 10.1097/CM9.0000000000000827.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 19, 2017

First Posted

March 3, 2017

Study Start

September 1, 2016

Primary Completion

September 1, 2017

Study Completion

March 1, 2018

Last Updated

June 6, 2018

Record last verified: 2018-06

Data Sharing

IPD Sharing
Will not share

Locations